IL96450A - Pharmaceutical preparations containing a history of 1,3-bistriazolyl - Google Patents

Pharmaceutical preparations containing a history of 1,3-bistriazolyl

Info

Publication number
IL96450A
IL96450A IL9645090A IL9645090A IL96450A IL 96450 A IL96450 A IL 96450A IL 9645090 A IL9645090 A IL 9645090A IL 9645090 A IL9645090 A IL 9645090A IL 96450 A IL96450 A IL 96450A
Authority
IL
Israel
Prior art keywords
pharmaceutical preparation
weight
polyethylene glycol
triazole derivative
denotes
Prior art date
Application number
IL9645090A
Other languages
English (en)
Hebrew (he)
Original Assignee
Mack Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mack Chem Pharm filed Critical Mack Chem Pharm
Publication of IL96450A publication Critical patent/IL96450A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9645090A 1989-11-29 1990-11-22 Pharmaceutical preparations containing a history of 1,3-bistriazolyl IL96450A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (1)

Publication Number Publication Date
IL96450A true IL96450A (en) 1994-10-21

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9645090A IL96450A (en) 1989-11-29 1990-11-22 Pharmaceutical preparations containing a history of 1,3-bistriazolyl

Country Status (29)

Country Link
US (1) US5118698A (de)
EP (1) EP0430149B1 (de)
JP (1) JPH0660097B2 (de)
KR (1) KR940000066B1 (de)
CN (1) CN1035357C (de)
AT (1) ATE102051T1 (de)
AU (1) AU626480B2 (de)
BR (1) BR9006025A (de)
CA (1) CA2030911C (de)
CY (1) CY1970A (de)
CZ (1) CZ282898B6 (de)
DE (2) DE3939492A1 (de)
DK (1) DK0430149T3 (de)
EG (1) EG19557A (de)
ES (1) ES2062271T3 (de)
FI (1) FI103713B (de)
HK (1) HK216896A (de)
HU (1) HU220867B1 (de)
IE (1) IE64672B1 (de)
IL (1) IL96450A (de)
MX (1) MX23518A (de)
MY (1) MY104540A (de)
NO (1) NO180475C (de)
NZ (1) NZ236255A (de)
PT (1) PT96003B (de)
RU (1) RU2038080C1 (de)
SK (1) SK280599B6 (de)
YU (1) YU227290A (de)
ZA (1) ZA909549B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0532546B1 (de) * 1990-05-10 1998-03-18 Bechgaard International Research And Development A/S Pharmazeutische zubereitung enthaltend n-glykofurole und n-äthylenglykole
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
MXPA03007766A (es) * 2001-02-28 2004-03-16 Akzo Nobel Nv Emulsiones inyectables de agua en aceite.
AU2003210517A1 (en) 2002-02-04 2003-09-02 Elan Pharma International, Ltd. Drug nanoparticles with lysozyme surface stabiliser
US20040258757A1 (en) * 2002-07-16 2004-12-23 Elan Pharma International, Ltd. Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (de) * 1982-06-09 1984-10-22 Pfizer
AU4882685A (en) * 1984-10-19 1986-04-24 Schering Corporation 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4- difluorophenyl) propane

Also Published As

Publication number Publication date
EP0430149A3 (en) 1991-09-25
HUT57039A (en) 1991-11-28
NO180475C (no) 1997-04-30
EP0430149A2 (de) 1991-06-05
ES2062271T3 (es) 1994-12-16
JPH0660097B2 (ja) 1994-08-10
AU6706590A (en) 1991-08-08
HK216896A (en) 1996-12-27
ATE102051T1 (de) 1994-03-15
DK0430149T3 (da) 1994-03-28
EP0430149B1 (de) 1994-03-02
RU2038080C1 (ru) 1995-06-27
AU626480B2 (en) 1992-07-30
FI103713B1 (fi) 1999-08-31
ZA909549B (en) 1992-06-24
HU220867B1 (en) 2002-06-29
CN1035357C (zh) 1997-07-09
CN1052046A (zh) 1991-06-12
NZ236255A (en) 1992-02-25
CA2030911A1 (en) 1991-05-30
KR910009286A (ko) 1991-06-28
IE64672B1 (en) 1995-08-23
FI905814A (fi) 1991-05-30
CZ595390A3 (en) 1997-06-11
EG19557A (en) 1997-08-31
NO905106L (no) 1991-05-30
NO905106D0 (no) 1990-11-26
BR9006025A (pt) 1991-09-24
US5118698A (en) 1992-06-02
JPH03176421A (ja) 1991-07-31
SK595390A3 (en) 2000-04-10
FI905814A0 (fi) 1990-11-26
MX23518A (es) 1993-04-01
DE69007029T2 (de) 1994-06-09
NO180475B (no) 1997-01-20
DE69007029D1 (de) 1994-04-07
CZ282898B6 (cs) 1997-11-12
CA2030911C (en) 1995-02-07
FI103713B (fi) 1999-08-31
PT96003B (pt) 1998-01-30
CY1970A (en) 1997-09-05
IE904282A1 (en) 1991-06-05
MY104540A (en) 1994-04-30
PT96003A (pt) 1991-09-13
YU227290A (sh) 1993-10-20
DE3939492A1 (de) 1991-06-06
KR940000066B1 (ko) 1994-01-05
SK280599B6 (sk) 2000-04-10

Similar Documents

Publication Publication Date Title
EP0546018B1 (de) Florfenicol enthaltendes arzneimittel
AP1235A (en) NMDA receptor agonist pharmaceutical compositions.
JP7464995B2 (ja) 液体薬学的製剤
CA2030911C (en) Pharmaceutical preparations
EP0298192B1 (de) Stabile, injizierbare Lösungen von Salzen von Vincristin
EP0769951B1 (de) Oxytetracyclin enthaltendes arzneimittel mit verzögerter wirksoffabgabe
US5886018A (en) Pharmaceutical composition for parenteral administration containing an indole-carboxylic acid
US6841576B2 (en) Anti-hypertensive composition and methods of treatment
IE781425L (en) Injectable chloroamphenicol solution
US4389414A (en) Prostaglandin compositions
JP3098275B2 (ja) トルナフテート含有液剤

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees